Search Count: 11
 |
Erap1 In Complex With 1-[2-(5-Bromo-7-Fluoro-2-Oxo-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]-4,4-Difluorocyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2026-05-06 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, SIN, PO4, EDO, A1JVE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-06
Ligands: ZN, SIN, PO4, EDO, A1JVE
 |
Erap1 In Complex With 1-[2-(6-Bromo-2,2-Difluoro-3-Oxo-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVD |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVD
 |
Erap1 In Complex With 1-[2-(2-Oxo-5-Phenyl-2,3-Dihydro-1,3-Benzoxazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, MLT, EDO, A1JVG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, MLT, EDO, A1JVG
 |
Erap1 In Complex With 1-[2-(5-Chloro-2-Oxo-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVH
 |
Erap1 In Complex With 1-[2-(3-Oxo-6-Phenyl-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVF |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVF
 |
Pi3 Kinase Delta In Complex With 3[6(Morpholin4Yl)Pyridin2Yl]Phenol
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2019-09-11 Classification: TRANSFERASE Ligands: G5T |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2019-09-11
Ligands: G5T
 |
Pi3 Kinase Delta In Complex With 3{6[(1S,6R)3Oxabicyclo[4.1.0]Heptan6Yl]Pyridin2Yl}Phenol
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2019-09-11 Classification: TRANSFERASE Ligands: G62 |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2019-09-11
Ligands: G62
 |
Pi3 Kinase Delta In Complex With 3[6(Oxan4Yl)Pyridin2Yl]Phenol
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2019-09-11 Classification: TRANSFERASE Ligands: G68 |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2019-09-11
Ligands: G68
 |
Crystal Structure Of Human Atad2 Bromodomain In Complex With N-(4-Bromo-3-((3-Methylpiperidin-1-Yl)Sulfonyl)Phenyl)-2-(2,5-Dioxoimidazolidin-1-Yl)Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2019-08-21 Classification: TRANSCRIPTION Ligands: EDO, SO4, KW5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-08-21
Ligands: EDO, SO4, KW5
 |
Crystal Structure Of Human Atad2 Bromodomain In Complex With N-(4-Chloro-3-(N,N-Dimethylsulfamoyl)Phenyl)-2-(2,5-Dioxo-3',4'-Dihydro-2'H-Spiro[Imidazolidine-4,1'-Naphthalen]-1-Yl)Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2019-08-21 Classification: TRANSCRIPTION Ligands: EDO, SO4, KVZ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-08-21
Ligands: EDO, SO4, KVZ
 |
Crystal Structure Of Human Atad2 Bromodomain In Complex Withn-(3-(Azepan-1-Ylsulfonyl)-4-Methylphenyl)-2-(4,4-Dimethyl-2,5-Dioxoimidazolidin-1-Yl)Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2019-08-21 Classification: TRANSCRIPTION Ligands: EDO, KVT, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-08-21
Ligands: EDO, KVT, SO4